ViCentra secured $85 million in Series D funding led by Innovation Industries to accelerate manufacturing expansion and launch of its next-generation Kaleido 2 patch pump for insulin delivery. The device integrates with Diabeloop's automated insulin algorithm and Dexcom CGM sensors, offering the smallest and lightest pump in its class. Currently marketed in Germany, France, and the Netherlands, ViCentra plans regulatory submissions in the EU and US, targeting fast healthcare provider uptake and commercial scale-up.